Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Shangbay Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
Shangbay Capital

Shangbay Capital

Operating

Shangbay Capital, LLC: A venture capital firm investing in early-stage medical and mobile healthcare startups in the US and China.

Location
Palo Alto, CA, US
Founded
2015
Firm
Compare
Portfolio
Employees
Website

Shangbay Capital is a venture capital firm focused on early-stage investments in medical devices, biotechnology, and healthcare technology sectors. Based in the heart of innovation, the firm primarily targets companies in the United States and China, providing venture equity participation to promising startups in these fields.

The firm's portfolio includes notable companies such as Ceribell, Flare Therapeutics, and Noah Medical. Shangbay Capital emphasizes building relationships with best-in-class investors, entrepreneurs, key opinion leaders, and industry innovators. Their investment philosophy centers on identifying disruptive companies addressing high-impact challenges in healthcare, supporting founders with the potential to revolutionize the industry.

Shangbay Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments33
Current Portfolio Count25
Total Portfolio Exits1

Top Investment Stages

Series A16 (51.6%)
Series B7 (22.6%)
Series D3 (9.7%)
Series Unknown3 (9.7%)
Series C2 (6.5%)

Stage Mix

Series A 52%Series B 23%Series D 10%Series Unknown 10%Series C 6%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Avation Medical logo

Avation Medical

Laplace Interventional logo

Laplace Interventional

Luminopia logo

Luminopia

Presidio Medical logo

Presidio Medical

Solenic Medical logo

Solenic Medical

Noah Medical logo

Noah Medical

Flare Therapeutics logo

Flare Therapeutics

Setpoint Medical logo

Setpoint Medical

Telesair logo

Telesair

Contraline logo

Contraline

Huma.AI logo

Huma.AI

IgGenix logo

IgGenix

Neuro42 logo

Neuro42

Emboline logo

Emboline

Lucira Health logo

Lucira Health

Aqua Medical logo

Aqua Medical

OrthoFX logo

OrthoFX

Zeto logo

Zeto

Zap Surgical Systems logo

Zap Surgical Systems

Meditrina logo

Meditrina

Corinth MedTech logo

Corinth MedTech

Apostle logo

Apostle

Atia Vision logo

Atia Vision

NeuroVasc Technologies logo

NeuroVasc Technologies

Refuge Biotechnologies logo

Refuge Biotechnologies

Shangbay Capital - Similar Investment Firms

Flare Capital Partners logo

Flare Capital Partners

flarecapital.com

Mission Bay Capital logo

Mission Bay Capital

Bay Partners logo

Bay Partners

baypartners.com

Madison Bay Capital Partners logo

Madison Bay Capital Partners

madbaycap.com

Boutique Venture Partners logo

Boutique Venture Partners

boutiquevc.com

Shorewind Capital logo

Shorewind Capital

Banyan Pacific logo

Banyan Pacific

banyanpac.com

XSeed Capital logo

XSeed Capital

xseedcap.com

YuanMing Capital logo

YuanMing Capital

Z5 Capital logo

Z5 Capital

Bay City Capital logo

Bay City Capital

baycitycapital.com

MBX Capital logo

MBX Capital

mbxcapital.com

Seae Ventures logo

Seae Ventures

HealthTech Capital logo

HealthTech Capital

Emergent Medical Partners logo

Emergent Medical Partners

emvllp.com

Shangbay Capital - Classification

Also Known As
  • Shangbay Capital Management Company, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end